When was Junson Capital founded?

Junson Capital was founded in 2010.

Where is Junson Capital's headquarters located?

Junson Capital's headquarters is located in New York City (United States).

How many companies has Junson Capital invested in?

Junson Capital has invested in 12 companies, including Butterfly Medical & Full-Life Technologies.

Which companies has Junson Capital invested in lately?

Full-Life Technologies & Butterfly Medical are the latest investments by Junson Capital.

What sectors does Junson Capital focus on for investments?

Top sectors in Junson Capital's portfolio are Life Sciences (6 investments) and High Tech (5 investments).

What stages of companies does Junson Capital typically invest in?

Junson Capital primarily invests in Series B and Seed stages.

How many exits has Junson Capital been involved in?

Junson Capital's portfolio has seen 1 acquisition.

Junson Capital - 2026 Investor Profile, Portfolio, Team & Investment Trends

Q: How big is Junson Capital's investment team?

Junson Capital has a team of 12.

Junson Capital is a family office founded in 2010. It is primarily based out of New York City, United States. As of Jul 2026, Junson Capital is an active investor, having invested in 12 companies, with 2 new investments in the last 12 months. It primarily invests in Series A round in China based companies. Its investments are spread across a wide range of sectors from Life Sciences, High Tech. Its latest investment was a $110M Series D round in Full-Life Technologies on May 18, 2026, which also saw participation from Vivo Capital and SK biopharmaceuticals.

Overall, Junson Capital portfolio has seen 1 acquisition including key companies like Butterfly Medical, Full-Life Technologies and BridGene Biosciences. A lot of funds co-invest with Junson Capital, with names like Lapam Capital sharing a substantial percentage of its portfolio.

Junson Capital has a team of 12 people including 1 partner.

Key Metrics

Founded Year

2010

Location

New York City, United States

Portfolio Companies

Butterfly Medical, Full-Life Technologies & 10 more

Sectors of Investment

Life Sciences, High Tech & 8 more

Stages of Investment

Series B, Seed & 2 more

Locations of Investment

China, United States & 2 more

View Junson Capital's full profile

Junson Capital has a portfolio of 12 companies. Their most notable investments are in Full-Life Technologies and Full-Life Technologies.Their portfolio spans across China, United States, Israel and 1 more locations. They have invested in Life Sciences, High Tech, Transportation and Logistics Tech and 7 other sectors, across stages such as Series B, Seed and 2 more. Here is the list of top investments by Junson Capital:

1. Butterfly Medical

Developer of an implantable device for the treatment of benign prostatic hyperplasia (BPH). The company's flagship product is a non-surgical device that is different from a conventional surgical treatment that requires a certain level of recovery and involves complications. It claims that the device can be delivered at the comfort of the physician’s office and provides immediate relief.

Key facts about Butterfly Medical

Founded Year: 2014
Location: Yokneam Illit (Israel)
Stage: Acquired
Total Funding till date: $30M
Employee Count: 21 as on Jun 30, 2026
Investors: MedVenture Partners, New Rhein and 11 Others
Latest Funding Round: Series C, May 15, 2026, $*****
Highlight: Acquired

2. Full-Life Technologies

Provider of discovery, development, production, and logistics services for of nuclear medicines. The Company endeavors to tackle fundamental challenges affecting radiopharmaceuticals. It manufactures radiopharmaceutical drug products.

Key facts about Full-Life Technologies

Founded Year: 2021
Location: Shanghai (China)
Stage: Series D
Total Funding till date: $350M
Employee Count: 69 as on Jun 30, 2026
Investors: HSG, Vivo Capital and 18 Others
Latest Funding Round: Series D, May 18, 2026, $*****

3. BridGene Biosciences

Developer of small-molecule drugs for the treatment of cancer. The company utilizes its proprietary Chemoproteomics platform, IMTAC that enables the screening of small molecules against all the proteins in live cells to discover drug candidates for high value and hard-to-drug targets that cause diseases.

Key facts about BridGene Biosciences

Founded Year: 2018
Location: Sunnyvale (United States)
Stage: Series B
Total Funding till date: $78.5M
Employee Count: 31 as on Jun 30, 2026
Investors: GTJAI, ShenZhen GTJA Investment Group and 8 Others
Latest Funding Round: Series B, Oct 16, 2025, $*****
Highlight: Editors' Pick

4. Allotex

Allotex is developing therapeutic solutions for the treatment of presbyopia, hyperopia, myopia, and astigmatism. The therapy is based on tissue addition technology that uses precisely-shaped human corneal allografts to create contact lens or lens insert. The corneal allografts can be placed on top of or just under Bowman’s (no need to place them deep in the cornea). It can be made in any shape, diameter, and thickness.

Key facts about Allotex

Founded Year: 2016
Location: Zurich (Switzerland)
Stage: Series B
Total Funding till date: $46.7M
Employee Count: 30 as on Jun 30, 2026
Investors: Exor, KCK MedTech and 3 Others
Latest Funding Round: Series B, Dec 04, 2023, $*****
Highlight: Editors' Pick

5. WiBotic

Provider of wireless charging solutions for industrial robots. Their solution includes a development kit hardware for wireless charging, coupled with a wireless battery management system and fleet-level power management software. They have developed a proprietary Adaptive Wireless charging technology that provides a greater range of up to three times the diameter of the transmitting coil and efficiency. The product is currently available as a development kit which enables it to be integrated into robotic projects.

Key facts about WiBotic

Founded Year: 2015
Location: Seattle (United States)
Stage: Series A
Total Funding till date: $13.5M
Employee Count: 33 as on Jun 30, 2026
Investors: HEDA Ventures, Washington Research Foundation and 9 Others
Latest Funding Round: Series A, Dec 13, 2024, $*****
Highlight: Editors' Pick

View the full list of portfolio companies

Junson Capital has invested in 12 companies over the last 7 years, with an average of 2 new investments annually in the last 5 years. In 2025, it made 1 investment, while as of May 2026, it has made 3 investments in this year. Its most recent first time investment was in Butterfly Medical and most recent follow-on round was in Full-Life Technologies.

Here are Junson Capital's Year-on-Year Investment Trends:

Year	No. of Investments
Year	1^st Round	Follow-on	Total
2026 (YTD)	2	1	3
2025	0	1	1
2024	0	1	1
2023	2	0	2
2022	3	0	3
2021	2	0	2
2020	0	0	0
2019	3	0	3

View all investments by Junson Capital

Junson Capital has made 4 investments in Series B stage with an average round size of $39.7M, 3 investments in Seed stage with an average round size of $7M, 3 investments in Series A stage with an average round size of $21.4M and 2 investments in Series C stage with an average round size of $21M.

Here are Junson Capital's investments by stage:

Stage of entry	No. of Investments
Series B	4
Seed	3
Series A	3
Series C	2

Note: We have considered here, only first round of investments

View all investments by Junson Capital

Junson Capital has a diverse portfolio, with companies operating in the Life Sciences, High Tech, Industrial Goods and Manufacturing, Aerospace, Maritime and Defense Tech and Auto Tech. Notably, it has invested in 10 Tech companies, 9 Enterprise (B2B) companies, 6 Tech hardware companies and 2 companies focusing on Consumer (B2C).

Here are Junson Capital's investments by sector:

Sector	No. of Investments
Life Sciences	6
High Tech	5
Industrial Goods and Manufacturing	2
Aerospace, Maritime and Defense Tech	1
Auto Tech	1
Others	6

Note: We have considered here, only first round of investments

View all investments by Junson Capital

Junson Capital has made most investments in China (5), followed by United States where it has made 4 investments.

Here are Junson Capital's investments by geography:

Country	No. of Investments
China	5
United States	4
Israel	2
Switzerland	1

Note: We have considered here, only first round of investments

View all investments by Junson Capital

Junson Capital has made 3 investments in 2026 so far. Full-Life Technologies and Butterfly Medical are the latest among them.

Here are the most recent investments by Junson Capital:

Filter this list

Date	Company	Location	Round Details	Round Amount	Co-Investors
May 18, 2026	Full-Life Technologies	China	Series D	3138	Vivo Capital [+7]
May 15, 2026	Butterfly Medical	Israel	Series C	1040	Europa [+2]
Apr 21, 2026	Motorevo	China	Series A	7766	Shenzhen Holdings [+3]
Sep 30, 2025	Full-Life Technologies	China	Series C	3013	Lapam Capital [+7]
Jan 03, 2024	Full-Life Technologies	China	Series B	3951	Prosperity7 Ventures [+5]

See more recent investments made by Junson Capital

1 company from Junson Capital's portfolio has been acquired. The most recent acquisition was Butterfly Medical in Jan 2019 by WELL Health Technologies Corp for $*****.

Here are Junson Capital's portfolio companies that got acquired most recently:

Filter this list

Company	Acquisition Date	First Invested on	First Round of Investment	Round Size
Butterfly Medical	Jan 02, 2019	May 15, 2026	Series C	3091

View all acquired companies in Junson Capital's portfolio

Junson Capital has a team of 12 members including 1 Partner and 7 Principals located in China and United States. Junson Capital's team does not sit on the board of any company as of now.

Here is a list of top team members in Junson Capital:

Name	Designation	Location	Board Memberships	Contact Details
Jiaxing Fan	Partner	-	-	-
Keyan Li	Principal	-	-	1 Email
Daisy Ce Shi	Principal	Hong Kong	-	1 Email
Wei Shen	Principal	Hong Kong	-	1 Email
Zhang Xiaowan	Principal	Chengdu	-	-
Sophia S	Principal	Palo Alto	-	-
Max Zhao	Principal	New York	-	1 Email
Bingdong Zhao	Principal	New York City	-	1 Email

View team details of Junson Capital

Over the past 7 years, 84 investors have co-invested in Junson Capital's portfolio companies. This includes funds and angels.

Invested before Junson Capital: New Rhein, Paul Merage and 33 others have invested in rounds before Junson Capital. There is 1 company where New Rhein has invested before Junson Capital and 1 company where Paul Merage has invested before Junson Capital.
Top Co-investors of Junson Capital: 28 investors entered a company along with Junson Capital. These include investors like Lapam Capital (2 companies).
Invested after Junson Capital: A total of 21 investors have invested in Junson Capital's portfolio after their investments. Top Investors include Prosperity7 Ventures (1 company) and Sky9 Capital (1 company).